Exxon Mobil Corporation(NYSE:XOM) gained in early trading after reporting earnings that beat Wall Street estimates.
The energy producer estimated that Q1 EPS declined 1% from a year earlier to $2.10, beating the consensus forecast of $1.88 measured by Capital IQ. Revenue fell 1% from the prior year to $106.8 billion, missing the analyst forecast of $111 billion. ExxonMobil rose 0.3% to $102.73 in early trading. It reached an all-time high of $102.57 a share during regular trading on April 28.
Exxon Mobil Corporation(NYSE:XOM) has a 50 day moving average of $97.40 and a 200 day average of $95. The current quarter consensus EPS is $7.53.
Advaxis, Inc.(NASDAQ:ADXS) shares were higher nearly 6% in recent pre-market trade after saying the U.S. Food and Drug Administration has granted an orphan drug designation to its ADXS-HPV treatment of Stage II-IV invasive cervical cancer.
ADXS is trading near the lower end of the 52-week range between $2.46 and $11.70.
The designation is intended for diseases that affect less than 200,000 people in the U.S. and gives the company right to clinical protocol assistance with the FDA, as well as annual grant funding, tax credits, waiver of PDUFA filing fees, and potentially a seven year market exclusivity period.
Advaxis, Inc.(NASDAQ:ADXS) has a 50 day moving average of $3.43 and a 200 day average of $4.07. The current quarter consensus EPS is $-0.97.
Inteliquent Inc(NASDAQ:IQNT) is higher in pre-market trading after the company reported financial results for Q1 that topped analysts’ expectations, and raised its guidance for fiscal 2014 revenue above Street estimates.
Shares are up 6.23% at $14.49, with a 52-week range of $3.90 – $15.31.
The company, which provides solutions for voice, data, and hosted services globally, reported Q1 net income of $9.2 million or $0.28 per share, compared with $6.9 million or $0.21 per share in the prior-year period. The Capital IQ analyst estimate is for $0.24 per share.
Inteliquent Inc(NASDAQ:IQNT) has a 50 day moving average of $14.07 and a 200 day average of $12.30. The current quarter consensus EPS is $0.90.